This analysis examines the lack of availability of medications within several African nations. One of the primary drivers of medicine availability is the lack of marketing authorization for existing products with these nations regulatory bodies. Instead the study finds that drugmakers have been over-applying for less medically critical medicines, slowing down the process due to a lack of regulatory agency bandwidth.

doi: https://dx.doi.org/10.1177/01410768231181263